Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Provision of information on the organization of renal replacement therapy (RRT) in emergency medicine in hospitals of the Moscow Healthcare Department in the context of a pandemic of the novel coronavirus infection SARS-CoV2 (COVID-19). Materials and methods. The annual reports of the Chief External Expert in Nephrology for 2019-2020 were used. Data were obtained from 43 healthcare organizations (HCO) that use RRT methods, of which 33 HCO used RRT methods for patients with COVID-19. Results and conclusion. The COVID-19 pandemic led to a significant increase in the number of patients receiving RRT in the ICU, amounting to 9434 (of which with COVID-19 - 34.7%), which is 20.7% more than in 2019. Also, the number of patients with acute kidney injury (AKI) and “extrarenal indications” receiving RRT increased in 2020; an increase compared to 2019 amounted to 39.3 and 38.9%, respectively. There were 33.6 and 32.4% patients with COVID-19 in these groups, respectively. At the same time, the number of patients with CKD (55.2% - patients with COVID-19) who underwent RRT in the ICU decreased by 8.1% compared to 2019. The total number of RRT procedures in 2020 increased by 15% compared to 2019, with 34% of the total number for the year performed in patients with COVID-19 Compared to 2019, there was a statistically significant increase in mortality among ICU patients who received RRT in 2020, which amounted to 33.6% and 46.6%, respectively. The mortality rate of patients with COVID-19 was 62.5%, without COVID-19 - 38.1%.

Full Text

Restricted Access

About the authors

Sergey I. Rey

N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department; Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: fanwal@mail.ru
Cand. Sci. (Med.), Senior Researcher; Leading Specialist a Moscow, Russia; Moscow, Russia

Nadezhda V. Vasina

Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: vasina-olimp@mail.ru
Cand. Sci. (Med.), Head of the Organizational and Methodological Department for Nephrology Moscow, Russia

Gennady A. Berdnikov

N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department

Email: berdnikovga@sklif.mos.ru
Cand. Sci. (Med.), Senior Researcher Moscow, Russia

Lyudmila V. Marchenkova

Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: marchen16@mail.ru
Cand. Sci. (Med.), Specialist Moscow, Russia

Oleg N. Kotenko

City Clinical Hospital № 52 of the Moscow Department of Healthcare

Email: olkotenko@yandex.ru
Cand. Sci. (Med.), Chief External Expert in Nephrology of the Moscow Healthcare Department, Head Moscow, Russia

References

  1. Gagliardi I., Patella G., Michael A., et al. COVID-19 and the Kidney: From Epidemiology to Clinical Practice. J Clin Med. 2020;9(8):2506. Doi: 10.3390/ jcm9082506.
  2. Hansrivijit P., Qian C, Boonpheng B., et al. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. JInvestig Med. 2020;68(7):1261-1270. doi: 10.1136/jim-2020-001407.
  3. Shao M., Li X., Liu F., et al. Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: A systematic review and metaanalysis of 40 studies and 24,527 patients. Pharmacol Res. 2020;161:105107. doi: 10.1016/j.phrs.2020.105107.
  4. Gabarre P., Dumas G., Dupont T., et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020; 46(7):1339-1348. doi: 10.1007/s00134-020-06153-9
  5. Vinayagam S., Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431. doi: 10.1016/jdfs.2020.118431.
  6. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
  7. Cunningham P.N., Dyanov H.M., Park P., et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol. 2002;168(11):5817-23. doi: 10.4049/jimmunol.168.11.5817.
  8. Su H., Yang M., Wan C., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219-227. doi: 10.1016/j.kint.2020.04.003.
  9. Рей С.И., Васина Н.В., Марченкова Л.В., Котенко О.Н. Принципы организации заместительной почечной терапии в неотложной медицине Департамента здравоохранения города Москвы. Клиническая нефрология. 2019;(4):11-16. Doi: https://dx.doi.org/10.18565/nephrology.2019.4.11-16.
  10. Friedrich J.O., Wald R., Bagshaw S.M. et al. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16(4):R146. doi: 10.1186/cc11458.
  11. Robbins-Juarez S.Y., Qian L., King K.L., et al. Outcomes for Patients with COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis Kidney. Int Rep. 2020;5(8):1149-60. doi: 10.1016/j.ekir.2020.06.013.
  12. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-1012. doi: 10.1016/S0140-6736(20) 30566-3.
  13. Gabarre P., Dumas G., Dupont T., et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339-1348. doi: 10.1007/s00134-020-06153-9
  14. Pei G., Zhang Z., Peng J., et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020;31(6):1157-65. doi: 10.1681/ASN.2020030276.
  15. Muner M.B., Lukitsch I., Torres-Ortiz A.E., et al. Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 2020;1(7): 614-622. doi: 10.34067/KID.0002652020.
  16. ICNARC report on COVID-19 in critical care: England, Wales and Northern Ireland 26 March 2021. Available at: https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports/ICNARC_COVID-19_Report_2021-03-26.pdf.pdf [Accessed April 13, 2021].
  17. Flythe J.E., Assimon M.M., Tugman M.J., et al. STOP-COVID Investigators. Characteristics and Outcomes of Individuals with Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021;77(2):190-203.e1. doi: 10.1053/j.aakd.2020.09.003.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies